Algo version: 0.98b
Fagron NV is listed at the PNK Exchange
Fagron NV [ARSUF]
PNK Sector: Healthcare Industry:Drug Manufacturers Specialty Generic

Is Fagron NV stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Fagron NV pays dividends. Last time was Thursday 23rd of May 2024 where the investors holding the stock on Tuesday 21st of May 2024 were paid $0.35394 per share. Over the last 6 times between 2018 and 2024, Fagron NV has paid $1.36773285 with an average of $0.23 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Fagron NV 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was $17.73, you would have made a profit of $2.30 per share or 12.97%

No, the average daily trading liquidity for Fagron NV is $12 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Fagron NV has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.34, the company's ability to pay off the debt is normal. Fagron NV has a good net profit margin of 9.50% and should have high tolerances against inflation.

We have calculated the inflation risk for Fagron NV to be low [0.4 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.